1. Introduction {#sec1}
===============

Neonatal jaundice is the leading cause of hospital admission and re-hospitalization in the first week of life worldwide [@bib1], [@bib2], [@bib3]. Appropriate treatment with phototherapy and/or exchange transfusion is effective in controlling excessive bilirubin levels in affected infants [@bib4], [@bib5]. Severe hyperbilirubinaemia may lead to acute bilirubin encephalopathy (ABE), kernicterus, and a significant risk of mortality in newborns [@bib6], [@bib7], [@bib8]. Survivors may also acquire long-term neurodevelopmental sequelae, such as cerebral palsy, sensorineural hearing loss, intellectual difficulties or gross developmental delays [@bib9], [@bib10], [@bib11], [@bib12].

Phototherapy is the single most common intervention used for the treatment of neonatal jaundice [@bib13].

The greater the surface area exposed, the greater the effectiveness of phototherapy [@bib14]. Light intensity and the area of light-exposed skin can also be increased through the use of reflecting surfaces [@bib15], [@bib16], [@bib17].

The purpose of this study was to evaluate the efficacy of phototherapy with reflectors versus conventional phototherapy in controlling neonatal indirect non-haemolytic hyperbilirubinemia.

2. Patients and methods {#sec2}
=======================

This study was carried out in the neonatal intensive care unit (NICU) of El-Nasr General Hospital, Port-Said, Egypt. A randomized controlled trial was conducted after obtaining informed consent from one or both parents of the neonates in this study. The study duration was one year, from June 2010 to June 2011. This study was approved by the ethics scientific committee at Cairo University hospital in accordance with the University bylaws for human research.

Full term (≥37 weeks gestation), healthy newborns were eligible for enrolment if they met the following criteria: postnatal age \>24 hours (h) and ≤10 days and had non-haemolytic indirect hyperbilirubinemia in the first week of life. We excluded preterm babies, cases with haemolytic jaundice, including Rh haemolytic disease, evidence of haemolysis in a peripheral smear, a positive Coomb\'s test, or a glucose-6-phosphate dehydrogenase (G6PD) deficiency. We also excluded cases requiring intensive care unit admission, including neonates with major congenital anomalies, or neonates with clinical or laboratory evidence of sepsis. The decision to start phototherapy was based on the AAP guidelines for term and near-term babies [@bib5].

All Participants were subjected to the following:a)A detailed history and full physical examination on admission and on a daily basis afterwards. In addition, neonates had their temperature monitored and potential side effects recorded, including presence of loose stools and skin rashes.b)Clinical investigations including the following: a complete blood count (CBC), and serum bilirubin on admission and every 12 h thereafter; with declining readings, bilirubin was measured once daily until hospital discharge. In addition, a reticulocyte count and maternal and neonatal blood group tests were collected, and Coombs test were conducted. The rate of bilirubin decline was calculated and compared in both groups.c)Randomization process: All eligible neonates were randomized into one of two groups: Group A infants (n = 30) received phototherapy with reflectors, and Group B infants (n = 30) received phototherapy without reflectors (conventional phototherapy). Randomization was conducted using opaque sealed envelopes that were indistinguishable between groups so that the investigators were unable to influence group designations. Each envelope had the assignment of the infant (Group A or B) with 30 envelopes for each group.

The phototherapy with reflectors unit utilized in the study consisted of two parallel lamps with an equal length of fixed stainless steel slices behind each lamp. The fixed slices allowed for 2 lamps to be used instead of 4 to reduce the cost of the complete unit. In addition, the slices may also increase phototherapy efficiency by potentially enhancing the rate of bilirubin decline, thus reducing the risk of hyperbilirubinemia complications. The measurements of the phototherapy unit included the following: height (distance) of the phototherapy from the incubator was 12 cm; length of 71 cm; width of 25 cm; height from the ground of 160 cm, and lamp length of 59 cm ([Fig. 1](#fig1){ref-type="fig"}). The sling measurements include the following: a length of 59 cm, a distance from the lamp of 10 cm, and a width of 10 cm. The phototherapy was placed at a distance of 45 cm from the baby. All babies were naked and wore eye pads and diapers while receiving phototherapy. The lamps were changed after every 1000 h of work.d)Statistical Analysis: Collected data were organized, tabulated and statistically analyzed using the statistical package for social sciences (SPSS), version 16 (SPSS Inc. USA), and ran on an IBM compatible computer using the Microsoft^®^ Windows 7 operating system. For qualitative data analyses, the frequency and percent distributions were calculated; for comparisons between groups, the Chi square (X^2^), Mann--Whitney or Wilcoxon tests were used. For quantitative data, the mean and standard deviations (SD) were calculated; for comparisons between two means, the student (t) test was used. For correlation analyses between two parameters, the bivariate Pearson\'s correlation coefficient was calculated; it was proportional if the sign was positive and inverse if the sign was negative. The correlation was considered mild (r \< 0.3), moderate (0.3 ≤ r ≤ 0.7) or powerful (r \> 0.7). For the interpretation of the results, a *P* value ≤ .05 was considered statistically significant.Figure 1Phototherapy with reflectors.

3. Results {#sec3}
==========

The details of the flow of the participants are shown in [Fig. 2](#fig2){ref-type="fig"}.Figure 2Study flow chart.

The two groups were comparable with respect to gender, age, weight, and mode of delivery. The total serum bilirubin and haemoglobin concentrations at the start of phototherapy were also similar between groups ([Table 1](#tbl1){ref-type="table"}). All mothers and their neonates were Rh positive. [Table 2](#tbl2){ref-type="table"} shows the outcome variables of the studied neonates with significant decreases in total serum bilirubin levels in both groups after discharge compared to their values on admission. A significant decline in serum bilirubin was observed after 12 h in group A compared to 24 h in group B ([Fig. 3](#fig3){ref-type="fig"}). The duration of the hospital stay was significantly lower in group A compared to group B ([Fig. 4](#fig4){ref-type="fig"}).Table 1Demographic data and variables at the start of phototherapy.Group A (phototherapy with reflectors) (n = 30)Group B (phototherapy without reflectors) (n = 30)TotalSignificanceGenderMales15 (50.0%)13 (43.3%)28 (46.7%)*P* = .60(NS)\*Females15 (50.0%)17 (56.7%)32 (53.3%)Mode of deliveryNormal vaginal delivery13 (43.3%)14 (46.7%)27 (45.0%)*P* = .79(NS)\*Cesarean section17 (56.7%)16 (53.3%)33 (55.0%)Weight2.93 (0.42)3.09 (0.35)3.01 (0.39)*P* = .12(NS)\*Age3.46 (0.89)3.83 (1.28)3.65 (1.11)*P* = .20(NS)\*TSB on admission17.88 (2.99)16.89 (2.71)17.38 (2.87)*P* = .18(NS)\*Haemoglobin concentration14.76 (1.57)14.44 (1.79)14.60 (1.68)*P* = .46(NS)\*WBCs count9.98 (1.29)9.12 (1.80)9.55 (1.61)*P* = .037(S)\*Platelet count325.60 (58.92)331.03 (61.13)328.32 (59.59)*P* = .72(NS)\*Reticulocyte percentage1.15 (0.44)1.52 (0.52)1.33 (0.52)*P* = .005(S)\**Maternal blood group*Group A7 (23.3%)5 (16.7%)12 (20.0%)Chi^2^ = 1.22^\#^,\
*P* = .74 (NS)\*Group B4 (13.3%)6 (20.0%)10 (16.7%)Group AB5 (16.7%)7 (23.3%)12 (20.0%)Group O14 (46.7%)12 (40.0%)26 (43.3%)*Neonatal blood group*Group A8 (26.7%)7 (23.3%)15 (25.0%)Chi^2^ = .39^\#^,\
*P* = .94 (NS)\*Group B5 (16.7%)6 (20.0%)11 (18.3%)Group AB2 (6.7%)3 (10.0%)5 (8.3%)Group O15 (50.0%)14 (46.7%)29 (48.3%)[^1]Table 2Outcome variables of the two groups.Outcome variableGroup A (phototherapy with reflectors) (n = 30)Group B (phototherapy without reflectors) (n = 30)*P* value**TSB**At 12 h14.95 (2.98)[a](#tbl2fna){ref-type="table-fn"}16.88 (2.51).009(S)At 24 h11.65 (2.92)[a](#tbl2fna){ref-type="table-fn"}14.25 (2.14)[b](#tbl2fnb){ref-type="table-fn"}.001(S)On second day8.73 (2.06)[a](#tbl2fna){ref-type="table-fn"}11.36 (2.01)[b](#tbl2fnb){ref-type="table-fn"}.001(S)On discharge7.26 (0.58)[a](#tbl2fna){ref-type="table-fn"}8.26 (1.46)[b](#tbl2fnb){ref-type="table-fn"}.001(S)**Duration of hospital stay**3.50 (0.51)4.43 (0.50).001(S)[^2][^3][^4]Figure 3Total bilirubin concentration in the two groups at different time intervals.Figure 4Comparison between group A and group B in regard to the duration of hospitalization.

There was a statistically significant moderate, inverse correlation between the duration of hospitalization and total bilirubin decrease in group A. The correlation between the duration of hospitalization and total bilirubin decrease was mild and non-significant in group B ([Table 3](#tbl3){ref-type="table"}).Table 3Correlation between duration of hospital stay and decrease in bilirubin (difference between the first and last days).Total serum bilirubin change in group ATotal serum bilirubin change in group BBilirubin change in all patientsHospital staysr−0.585−0.274−0.038p0.001(S)0.143(NS)0.772(NS)n.303060

Hyperthermia was the only observed complication in the two groups. There was no significant difference in the presence of hyperthermia between the two groups ([Table 4](#tbl4){ref-type="table"}).Table 4Incidence of complications in studied groups.Group AGroup BTotalComplicationsFever2 (6.7%)4 (13.3%)6 s (10.0%)No complications28 (93.3%)26 (86.7%)54 (90.0%)StatisticsX^2^ = 0.74, p = 0.38

4. Discussion {#sec4}
=============

The results of the current study suggest that the fixation of reflective stainless steel slings behind phototherapy lamps can accelerate the rate of total serum bilirubin decline and shorten the duration of hospitalization in neonates with non-haemolytic hyperbilirubinaemia without increasing phototherapy complications. A study performed by Djokomulijanto et al evaluated the use of white curtains around the beds of infants treated with phototherapy and reported a significantly greater rate of bilirubin decline and a dramatically shorter duration of phototherapy without an increase in complications in the study group compared to the control group [@bib16]. Similarly, another study evaluated a simple and relatively inexpensive method using a fluid bed to provide high-intensity double-surface (HIDS) phototherapy which increased the irradiance of phototherapy and the area of the body exposed, proving to be significantly more effective in reducing bilirubin than conventional phototherapy [@bib18].

In Hansen\'s study, using white pads around the infant\'s bed during phototherapy resulted in an irradiance increase and thus, shortened the duration of phototherapy [@bib19]. More recently, Babaei et al studied the effect of a white plastic cover around the phototherapy unit on hyperbilirubinemia in full term neonates and observed that the total serum bilirubin in the covered group during the first 48 h of treatment declined significantly compared to the control group; in addition, the study group also had a decreased duration of hospitalization and no increase in phototherapy complications [@bib20].

Additionally, a study conducted by Salehzadeh et al showed that the use of a mirror behind phototherapy lamps can enhance the effectiveness of phototherapy without increasing the risk of hyperthermia [@bib17].

Sivandan et al studied the effect of a sling application on the efficacy of phototherapy in healthy full term neonates with non-haemolytic jaundice and found no dramatic difference in the phototherapy duration between the study and control groups [@bib21]. Sivandan et al findings are the opposite of ours, which may be due to Sivandan\'s use of a cover with a low reflection coefficient. In our study, the neonates with haemolytic jaundice were excluded because they have rapidly rising serum bilirubin and a higher potential need for intensive phototherapy or exchange transfusion. The use of phototherapy with reflectors in such complex cases should be studied separately. Preterm babies were excluded from our study, as the guidelines for jaundice management are different from those for term babies. Preterm babies are also more susceptible to bilirubin encephalopathy due to the immaturity of their blood brain barrier and associated morbidities.

Our study has a few limitations: first, the sample size was limited, making it difficult to statistically determine important outcomes; second, we had no access to a photo radiometer to measure the average irradiance of our devices.

5. Conclusion {#sec5}
=============

The present study provided evidence for the efficacy and tolerability of phototherapy with reflectors in controlling serum bilirubin levels and shortening hospitalization time compared to conventional phototherapy.
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[^1]: All values, except *P* value\*, and Chi^2\#^ are expressed in number (%) or mean ± SD, S: significant, NS: non-significant.

[^2]: S: significant.

[^3]: Statistically significant decrease of levels in group A in comparison to their basal values.

[^4]: Statistically significant decrease of levels in group B in comparison to their basal values.
